| Sarah Zwarick, | |
|
587 E Middle Tpke, Manchester, CT 06040-3731 | |
| (860) 646-3888 | |
| (860) 645-4132 |
| Full Name | Sarah Zwarick |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 587 E Middle Tpke, Manchester, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003077579 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Zwarick, 587 E Middle Tpke, Manchester, CT 06040-3731 Ph: (860) 646-3888 | Sarah Zwarick, 587 E Middle Tpke, Manchester, CT 06040-3731 Ph: (860) 646-3888 |
News Archive
A.D.A.M., Inc., a leading provider of consumer health information and technology tools, announced today the release of TotalHealth, one of the most comprehensive platforms of consumer health information products available in the market. At the center of TotalHealth is A.D.A.M.'s award-winning Multimedia Encyclopedia along with 19 other products and services designed to increase consumer traffic to hospital websites.
Rush cardiologists are hoping that transplanted stem cells can regenerate damaged heart muscle in those who experience a first heart attack. The study involves an intravenous infusion of adult mesenchymal stem cells from healthy donor bone marrow that might possibly reverse damage to heart tissue.
Drinking two cups of hot chocolate a day may help older people keep their brains healthy and their thinking skills sharp, according to a study published in the August 7, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology.
Accentia Biopharmaceuticals, Inc. and its majority-owned subsidiary, Biovest International, Inc., today jointly announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to Revimmune, the Company's proprietary system-of-care based on high-dose administration of Cytoxan, for the prevention of graft-versus-host disease (GVHD) following bone marrow transplant.
The Advisory Board Company today announced financial results for the second quarter of its fiscal year ending March 31, 2010. Revenue for the quarter increased 1.2% to $58.3 million, from $57.6 million in the second quarter of fiscal 2009. Contract value grew 3.0% to $237.6 million as of September 30, 2009, up from $230.6 million as of September 30, 2008.
› Verified 2 days ago
Ms. Karen Franes Foley-schain, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 245 Redwood Rd, Manchester, CT 06040 Phone: 860-508-0332 | |
Krista Nordmark, Counselor Medicare: Not Enrolled in Medicare Practice Location: 587 E Middle Tpke, Manchester, CT 06040 Phone: 860-646-3888 Fax: 860-645-4132 | |
Sylvester Esangbedo, Counselor Medicare: Not Enrolled in Medicare Practice Location: 444 Center St, Manchester, CT 06040 Phone: 860-646-3888 Fax: 860-645-4132 | |
Elsa Reyes, Counselor Medicare: Medicare Enrolled Practice Location: 444 Center St, Manchester, CT 06040 Phone: 860-646-3888 Fax: 860-645-4132 | |
Aliya E Jasensky, Counselor Medicare: Not Enrolled in Medicare Practice Location: 444 Center St, Manchester, CT 06040 Phone: 860-646-3888 | |
Lynda Dyer, Counselor Medicare: Not Enrolled in Medicare Practice Location: 444 Center St, Manchester, CT 06040 Phone: 860-646-3888 |